CORRECTION: Nuvation Bio's SIGMA Phase 3 Study for Grades 2, 3, and 4 Glioma Brain Cancer
SEATTLE, WA, UNITED STATES, October 15, 2026 /EINPresswire.com/ -- The End Brain Cancer Initiative (EBCI) has partnered with Nuvation Bio, a global oncology company focused on tackling some of the toughest challenges in cancer treatment, to …